Transcription factors and structural proteins were employed as markers of glioma CSCs, including SOX2 (Hemmati et al. 2003), OCT4 (Kaufhold et al. 2016), NANOG (Suvà et al. 2014), and MYC (Kim et al. 2010). This evidence concerns the gene NANOG and central nervous system cancer.